Huakang Biomedical Holdings Company Limited announced earnings results for the first quarter ended March 30, 2021. For the first quarter, the company announced sales was CNY 4.888 million compared to CNY 2.056 million a year ago. Net loss was CNY 1.149 million compared to CNY 2.753 million a year ago. Basic loss per share from continuing operations was CNY 0.0029 compared to CNY 0.0069 a year ago.